We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

62 hedge funds and large institutions have $25.6M invested in RVL Pharmaceuticals plc Ordinary Shares in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

117% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 12

24% more funds holding

Funds holding: 50 → 62 (+12)

4% more capital invested

Capital invested by funds: $24.6M → $25.6M (+$959K)

Holders
62
Holders Change
+12
Holders Change %
+24%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
26
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SS
Sunbelt Securities
Texas
+$5.62M
2
SCM
Sio Capital Management
New York
+$3.06M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.73M
4
Millennium Management
Millennium Management
New York
+$2.23M
5
Marshall Wace
Marshall Wace
United Kingdom
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$601K
2
Morgan Stanley
Morgan Stanley
New York
-$390K
3
PAM
Panagora Asset Management
Massachusetts
-$322K
4
Walleye Capital
Walleye Capital
New York
-$217K
5
AIM
Alambic Investment Management
California
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
26
Spark Investment Management
New York
$88K +$148K +27,710 New
First Trust Advisors
27
First Trust Advisors
Illinois
$82K +$45.6K +8,567 +49%
Goldman Sachs
28
Goldman Sachs
New York
$78K +$14.3K +2,679 +12%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$71K +$1.84K +345 +2%
Morgan Stanley
30
Morgan Stanley
New York
$57K -$390K -73,262 -80%
COPPSERS
31
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$54K +$90.3K +16,950 New
PAM
32
Panagora Asset Management
Massachusetts
$53K -$322K -60,424 -78%
State of New Jersey Common Pension Fund D
33
State of New Jersey Common Pension Fund D
New Jersey
$53K +$89.3K +16,763 New
Two Sigma Investments
34
Two Sigma Investments
New York
$52K +$86.3K +16,200 New
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$43K – – –
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$42K – – –
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$40K +$751 +141 +1%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$39K +$65K +12,200 New
CSS
39
Cubist Systematic Strategies
Connecticut
$37K +$61.7K +11,583 New
FDCDDQ
40
Federation des caisses Desjardins du Quebec
Quebec, Canada
$36.5K – – –
HSBC Holdings
41
HSBC Holdings
United Kingdom
$36K -$108K -20,267 -64%
Wells Fargo
42
Wells Fargo
California
$36K +$35.8K +6,722 +145%
MAM
43
Meeder Asset Management
Ohio
$35K +$19.2K +3,597 +47%
State of Tennessee, Department of Treasury
44
State of Tennessee, Department of Treasury
Tennessee
$32K +$34.4K +6,463 +175%
PPA
45
Parametric Portfolio Associates
Washington
$32K +$53.7K +10,091 New
Citigroup
46
Citigroup
New York
$20K +$3.35K +630 +11%
RA
47
Royce & Associates
New York
$20K +$32.9K +6,184 New
AIG
48
American International Group
New York
$17K +$1.43K +268 +5%
Victory Capital Management
49
Victory Capital Management
Texas
$14K +$24.9K +4,682 New
PHK
50
Point72 Hong Kong
Hong Kong
$13K +$21.3K +4,004 New
1
2
3

RVLP Hedge Fund Activity: Q1 2020 in Review

62 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q1 2020, worth a combined $25.6M — up 3.9% from $24.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RVLP positions and 7 closed out — a net gain of 12 holders — while 26 added to existing stakes and 12 trimmed.

The largest buyer was Sunbelt Securities, opening a new position worth an estimated $5.62M. The largest seller was Oxford Asset Management, cutting an estimated $601K.

  • 62 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q1 2020, up from 50 in Q4 2019.
  • Funds reported $25.6M of RVL Pharmaceuticals plc Ordinary Shares stock for Q1 2020, up 3.9% quarter-over-quarter.
  • 19 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q1 2020 and 7 closed out, a net change of +12 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q1 2020 was Sunbelt Securities, an estimated $5.62M added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q1 2020 was Oxford Asset Management, an estimated $601K sold.

Based on aggregated 13F filings for Q1 2020.